Abstract
Recent studies have shown that the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) stimulates protein kinase C (PKC), whereas the ether-linked phospholipid 1-O-octadecyl-2-O-methyl-rac-glycerol-3-phosphocholine (ET-18-OCH3) inhibits PKC activity in vitro. Therefore, the antitumor effects of ET-18-OCH3 could be due to its inhibition of PKC activity and the effects of tumor promotion. TPA stimulates arachidonic acid release, prostaglandin synthesis, phosphatidylcholine synthesis and the degradation of phosphatidylcholine by phospholipase C in Madin Darby canine kidney (MDCK) cells. Therefore, we have determined the effects of ET-18-OCH3 on these consequences of TPA stimulation. Preliminary experiments determined that ET-18-OCH3 inhibited PKC partially purified from MDCK cells by ion-exchange chromatography on DEAE-cellulose. In addition, ET-18-OCH3, inhibited the TPA-stimulated phosphorylation of a 40,000-dalton protein in intact MDCK cells. These data indicate that ET-18-OCH3 is an effective inhibitor of PKC activity in MDCK cells. In addition, ET-18-OCH3 was found to inhibit arachidonic acid release and prostaglandin synthesis. The inhibition of prostaglandin synthesis appears to be secondary to inhibition of arachidonic acid release, since ET-18-OCH3 does not inhibit TPA-stimulated synthesis of prostaglandin H synthase or the activity of the enzyme directly (Parker, J., Daniel, L. W., and Waite, M. [1987]J. Biol. Chem. 262, 5385–5393). ET-18-OCH3 also inhibits TPA-stimulated phosphatidylcholine synthesis and phosphatidylcholine degradation by phospholipase C. These data provide evidence that the antineoplastic ether lipids inhibit the biochemical effects of the tumor promoter TPA in intact cells and indicate that this inhibition may have a role in their biological activities.
Similar content being viewed by others
Abbreviations
- TPA:
-
12-O-tetradecanoyl-phorbol-13-acetate
- PKC:
-
Ca2+-activated, phospholipid-dependent protein kinase
- MDCK:
-
Madin Darby canine kidney
- PC:
-
choline-containing phosphoglycerides
- CI:
-
1-(5-isoquinolinsulfonyl)piperazine
- CP 46,665:
-
4-aminomethyl-1-[2,3-(di-n-decycloxy)n-propyl]-4-phenylpiperidine dihydrochloride
- ET-18-OCH3 :
-
1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
- ET-18-H:
-
1-O-octadecylpropanediol-3-phosphocholine
- ET-18-S-OCH3 :
-
1-S-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
- TLC:
-
thin layer chromatography
- PC-PLC:
-
a TPA-stimulated phospholipase C that degrades PC
References
Daniel, L.W., King, L., and Waite, M. (1981)J. Biol. Chem. 256, 12830–12835.
Beaudry, G.A., King, L., Daniel, L.W., and Waite, M. (1982)J. Biol. Chem. 257, 10973–10977.
Daniel, L.W., Waite, M., and Wykle, R.L. (1986)J. Biol. Chem. 261, 9128–9132.
Besterman, J.M., Duronio, V., and Cuatrecasas, P. (1986)Proc. Natl. Acad. Sci. USA 83, 6785–6789.
Kinzel, V., Kreibich, G., Hecker, E., and Süss, R. (1979)Cancer Res. 39, 2743–2750.
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., and Nishizuka, Y. (1982)J. Biol. Chem. 257, 7847–7851.
Ashendel, C.L. (1985)Biochim. Biophys. Acta 822, 219–242.
Helfman, D.M., Barnes, K.C., Kinkade, J.M. Jr., Vogler, W.R., Shoji, M., and Kuo, J.F. (1983)Cancer Res. 43, 2955–2961.
Gerard, C., McPhail, L.C., Marfat, A., Stimler-Gerard, N.P., Bass, D.A., and McCall, C.E. (1986),J. Clin. Invest. 77, 61–65.
Shoji, M., Vogler, W.R., and Kuo, J.F. (1985)Biochem. Biophys. Res. Commun. 127, 590–595.
Berdel, W.E., Bausert, W.R.E., Fink, U., Rastetter, J., and Munder, P.G. (1981)Anticancer Res. 1, 345–352.
Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y., (1984)Biochemistry 23, 5036–5041.
Berdel, W.E., Schick, H.D., Fink, U., Reichert, A., Ulm, K., and Rastetter, J. (1985)Cancer Res. 45, 1206–1213.
Wolff, J.S., Hemsworth, G.R., Kraska, A.R., Hoffman, W.W., Figdor, S.K., Fisher, D.O., Jakowski, R.M., Niblick, J.F., and Jensen, K.E. (1982)Cancer Immunol. Immunother. 12, 97–103.
Morris-Natschke, S., Surles, J.R., Daniel, L.W., Berens, M.E., Modest, E.J., and Piantadosi, C. (1986)J. Med. Chem. 29, 2114–2117.
Daniel, L.W. (1985) inInositol and Phosphoinositides: Metabolism and Regulation, pp. 537–543, Humana Press, Clifton, NJ.
Vogler, W.R., Whigham, E., Bennett, W.D., and Olson, A.C. (1985)Exp. Hematol. 13, 629–633.
Parker, J., Daniel, L.W., and Waite, M. (1987)J. Biol. Chem. 262, 5385–5393.
Choy, P.C., and Vance, D.E. (1978)J. Biol. Chem. 253, 5163–5167.
Parthasarathy, S., and Baumann, W.J. (1979)Biochem. Biophys. Res. Commun. 91, 637–642.
Herrmann, D.B.J., and Neumann, H.A. (1986)J. Biol. Chem. 261, 7742–7747.
Herrmann, D.B.J. (1985)J. Natl. Cancer Inst. 75, 423–430.
Kreutter, D., Caldwell, A.B., and Morin, M.J. (1985)J. Biol. Chem. 260, 5979–5984.
Yamamoto, S., Gatoh, H., Aziu, E., and Kato, R. (1985)J. Biol. Chem. 260, 14230–14234.
Kraft, A.S., Smith, J.B., and Berkow, R.L. (1986)Proc. Natl. Acad. Sci. USA 83, 1334–1338.
McNamara, M.J.C., Schmitt, J.D., Wykle, R.L., and Daniel, L.W. (1984)Biochem. Biophys. Res. Commun. 122, 824–830.
May, W.S., Lapetina, E.G., and Cuatrecasas, P. (1986)Proc. Natl. Acad. Sci. USA 122, 1281–1284.
Author information
Authors and Affiliations
About this article
Cite this article
Daniel, L.W., Etkin, L.A., Morrison, B.T. et al. Ether lipids inhibit the effects of phorbol diester tumor promoters. Lipids 22, 851–855 (1987). https://doi.org/10.1007/BF02535543
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02535543